Skip to main content

Cartesian Therapeutics, Inc.

RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001453687

No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.

13F holders, Q2 2026

Institutional positions in Cartesian Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
94
+12 vs. Q1 2026
Shares held
8.68M
+1.54M (+21.5%) vs. Q1 2026
Total value
$90.4M
+$46.5M (+105.8%) vs. Q1 2026
New holders
24
44 more added
Sold out
12
12 more reduced

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RNAC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 94 institutions
Q1 2021: 98 institutionsQ2 2021: 101 institutionsQ3 2021: 103 institutionsQ4 2021: 106 institutionsQ1 2022: 102 institutionsQ2 2022: 93 institutionsQ3 2022: 97 institutionsQ4 2022: 86 institutionsQ1 2023: 95 institutionsQ2 2023: 92 institutionsQ3 2023: 87 institutionsQ4 2023: 80 institutionsQ1 2024: 70 institutionsQ2 2024: 62 institutionsQ3 2024: 64 institutionsQ4 2024: 68 institutionsQ1 2025: 72 institutionsQ2 2025: 66 institutionsQ3 2025: 68 institutionsQ4 2025: 67 institutionsQ1 2026: 83 institutionsQ2 2026: 94 institutions
Value heldQ2 2026: $90.4M
Q1 2021: $245.1MQ2 2021: $219.2MQ3 2021: $216.7MQ4 2021: $185.7MQ1 2022: $71.6MQ2 2022: $79.3MQ3 2022: $104.9MQ4 2022: $62.8MQ1 2023: $65.1MQ2 2023: $63.2MQ3 2023: $57.2MQ4 2023: $37.8MQ1 2024: $35.3MQ2 2024: $88.3MQ3 2024: $110.3MQ4 2024: $119.5MQ1 2025: $86.7MQ2 2025: $66.5MQ3 2025: $60.9MQ4 2025: $37.2MQ1 2026: $43.9MQ2 2026: $90.4M
Institutions holding RNAC and their total value by quarter
QuarterHoldersValue
Q2 202694$90.4M
Q1 202683$43.9M
Q4 202567$37.2M
Q3 202568$60.9M
Q2 202566$66.5M
Q1 202572$86.7M
Q4 202468$119.5M
Q3 202464$110.3M
Q2 202462$88.3M
Q1 202470$35.3M
Q4 202380$37.8M
Q3 202387$57.2M
Q2 202392$63.2M
Q1 202395$65.1M
Q4 202286$62.8M
Q3 202297$104.9M
Q2 202293$79.3M
Q1 2022102$71.6M
Q4 2021106$185.7M
Q3 2021103$216.7M
Q2 2021101$219.2M
Q1 202198$245.1M

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Cartesian Therapeutics, Inc.; share changes are against Q1 2026.

Institutions holding RNAC in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Mirae Asset Global Investments Co., Ltd.0$00.00%−3,715−100.0%Sold out
UMA Financial Services, Inc.0$00.00%−144−100.0%Sold out
Optiver Holding B.V.0$00.00%−104−100.0%Sold out
MAI Capital Management0$00.00%−24−100.0%Sold out
Root Financial Partners, LLC0$00.00%−14−100.0%Sold out
Wealth Preservation Advisors, LLC0$00.00%−1−100.0%Sold out
CWM, LLC––––Not filed